| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1525-1470.2008.00626.X |
| P698 | PubMed publication ID | 18429772 |
| P2093 | author name string | Ilona J Frieden | |
| Christine Kilcline | |||
| P2860 | cites work | Spontaneous regression of angiomas in children; twenty-two years' observation covering 236 cases. | Q55036954 |
| Hemangiomas: evaluation and treatment | Q30669808 | ||
| Hemangiomas in children | Q30732724 | ||
| Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis | Q30850679 | ||
| The incidence and significance of birthmarks in a cohort of 4,641 newborns | Q34266047 | ||
| Hemangiomas of infancy. | Q35094165 | ||
| Strawberry hemangioma in preterm infants | Q44309859 | ||
| The incidence of birthmarks in Israeli neonates. | Q51046943 | ||
| Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. | Q51766049 | ||
| P433 | issue | 2 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 168-173 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Pediatric Dermatology | Q15753278 |
| P1476 | title | Infantile hemangiomas: how common are they? A systematic review of the medical literature | |
| P478 | volume | 25 |
| Q46953266 | A 65-year-old woman diagnosed with PHACE syndrome |
| Q92616199 | A multi-disciplinary, multimodal approach for the management of vascular anomalies |
| Q43521340 | A prospective study of infantile hemangiomas with a focus on incidence and risk factors |
| Q34017051 | A retrospective study to classify surgical indications for infantile hemangiomas |
| Q39778761 | A survey on clinical use of propranolol for infantile hemangiomas in mainland China |
| Q33896493 | Ablative fractional yttrium-scandium-gallium-garnet laser for scarring residual haemangiomas and scars secondary to their surgical treatment |
| Q38032235 | Airway hemangiomas in PHACE syndrome |
| Q36908121 | Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma |
| Q88213531 | Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma |
| Q94338482 | Answer: Can you identify this condition? |
| Q89786081 | Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies |
| Q37866836 | Arteriovenous malformation: a rare manifestation of PHACE syndrome |
| Q33931306 | Beta blockers: an innovation in the treatment of infantile hemangiomas |
| Q33832594 | Beta-blockers as therapy for infantile hemangiomas |
| Q38127617 | Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review |
| Q34592757 | COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2. |
| Q26769978 | Cardiovascular drugs in the treatment of infantile hemangioma |
| Q33883403 | Characteristic and follow-up of subglottic hemangiomas in Iranian children |
| Q38377887 | Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial |
| Q38083829 | Congestive heart failure with diffuse neonatal hemangiomatosis--case report and literature review |
| Q42731725 | Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth |
| Q90484644 | Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting |
| Q49932201 | Das infantile Hämangiom: Pathogenese und Wirkmechanismus von Propranolol |
| Q33778184 | Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome |
| Q33686573 | Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique |
| Q33802563 | Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model |
| Q37868666 | Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. |
| Q45756443 | Diverging racial trends in neonatal infantile hemangioma diagnoses, 1979-2006. |
| Q37799299 | Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas |
| Q89667081 | Elevated eosinophil levels observed in infantile hemangioma patients from Kaifeng, China |
| Q37734246 | Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. |
| Q37268517 | Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma |
| Q30486552 | Evaluation of the Compliance, Acceptance, and Usability of a Web-Based eHealth Intervention for Parents of Children With Infantile Hemangiomas: Usability Study |
| Q39148971 | Four cases of pediatric deep-seated/subcutaneous pyogenic granuloma: Review of literature and differential diagnosis. |
| Q35112393 | Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study |
| Q35190423 | Giant chorioangioma treated in utero via laser of feeding vessels with subsequent development of multifocal infantile hemangiomas |
| Q38108844 | Haemangioma: clinical course, complications and management |
| Q38595683 | Hair and Scalp Disorders in a Tuscan Pediatric Dermatological Outpatient Clinic: A Clinical and Epidemiological Evaluation |
| Q53196492 | Hemangioma of the diaphragm presenting with cardiac tamponade. |
| Q37877159 | Hemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics |
| Q36905623 | Incidence and clinical characteristics of periocular infantile hemangiomas. |
| Q38263431 | Incidence and treatment of infantile haemangioma in preterm infants |
| Q38694569 | Incidence, Treatment Patterns, and Health Care Costs of Infantile Hemangioma: Results of a Retrospective German Database Analysis. |
| Q37197527 | Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight |
| Q37796196 | Infantile Hemangioma |
| Q40659256 | Infantile Hemangiomas of the Lip: Patterns, Outcomes, and Implications |
| Q39327604 | Infantile Periocular Hemangioma |
| Q51867476 | Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. |
| Q42316796 | Infantile haemangiomas do not occur more frequently in children with congenital melanocytic naevi |
| Q47386049 | Infantile hemangioma: pathogenesis and mechanisms of action of propranolol |
| Q36875692 | Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis. |
| Q37059898 | Infantile hemangiomas: A review |
| Q38075847 | Infantile hemangiomas: an update |
| Q92342621 | Insulin-like growth factor 2 promotes the adipogenesis of hemangioma-derived stem cells |
| Q47694185 | Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas? |
| Q35879997 | Laser treatment of infantile hemangioma: A systematic review |
| Q38442054 | Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis |
| Q88142300 | MRI evaluation of peripheral vascular anomalies using time-resolved imaging of contrast kinetics (TRICKS) sequence |
| Q34052390 | Management of infantile hemangiomas: current trends |
| Q33433230 | Multifocal infantile haemangioma: a diagnostic challenge |
| Q37412758 | Novel mutations in one allele in a Chinese family with neurofibromatosis type 1: Including a complex insertion-deletion mutation |
| Q89124970 | Oral Propranolol in a Child With Infantile Hemangioma of the Urethra |
| Q36512006 | Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study |
| Q34087646 | PHACE syndrome in antenatally diagnosed posterior fossa anomaly |
| Q42383552 | PHACE syndrome misdiagnosed as a port-wine stain |
| Q51400068 | PHACE syndrome with growth hormone deficiency and absence of bilateral internal carotid arteries: a case report. |
| Q53132737 | PHACE syndrome with lip haemangioma, microphthalmos and persistent fetal vasculature. |
| Q55400781 | PHACE syndrome: clinical manifestations, diagnostic criteria, and management. |
| Q39177052 | Perianal Lesions in Children: An Updated Review |
| Q57382816 | Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma |
| Q37984637 | Pictorial review: Vascular anomalies of the head and neck. |
| Q38245087 | Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas |
| Q38081161 | Propranolol and infantile hemangiomas four years later: a systematic review |
| Q40042647 | Propranolol in the management of infantile hemangiomas: clinical response and predictors |
| Q33668380 | Propranolol in treatment of huge and complicated infantile hemangiomas in egyptian children |
| Q34050131 | Propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells |
| Q36299241 | Propranolol treatment for infantile hemangioma does not increase risk of childhood wheezing. |
| Q37197863 | Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. |
| Q89940771 | Propranolol, infantile haemangiomas, and serendipity: new use for an old drug |
| Q44668179 | Propranolol-resistant infantile haemangiomas. |
| Q35539585 | Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies |
| Q89177504 | Recommendations and a guideline for referral of infantile haemangioma to tertiary centres |
| Q35603555 | Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol |
| Q52656352 | Resolution of consumptive hypothyroidism secondary to infantile hepatic hemangiomatosis with combination propranolol and levothyroxine. |
| Q35032888 | Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study) |
| Q39794295 | Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration |
| Q89887046 | Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions |
| Q39267166 | Role of propranolol in hemangiomas |
| Q43449364 | Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy |
| Q49384897 | Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres |
| Q37957929 | Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial |
| Q51464896 | Subglottic infantile haemangioma: A rare but important consideration in young infants presenting with stridor. |
| Q53005216 | Successful treatment by coil embolization for infantile hemangioma with Kasabach-Meritt syndrome of newborn. |
| Q41717437 | The expression and function of miR-424 in infantile skin hemangioma and its mechanism |
| Q91604465 | The majority of skin lesions in pediatric primary care attention could be managed by Teledermatology |
| Q36697784 | The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma |
| Q51361044 | The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. |
| Q53008897 | Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. |
| Q39392041 | Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas |
| Q35571889 | Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study |
| Q38859269 | Transcriptional activation of Hedgehog pathway components in aggressive haemangioma. |
| Q34657458 | Treatment of Infantile Hemangioma in Regional Hospitals With eHealth Support: Evaluation of Feasibility and Acceptance by Parents and Doctors. |
| Q38662656 | Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events - a review of the literature |
| Q35154568 | Treatment of periorbital infantile haemangiomas: a systematic literature review on propranolol or steroids |
| Q92758741 | Two Cases of Oculofaciocardiodental (OFCD) Syndrome due to X-Linked BCOR Mutations Presenting with Infantile Hemangiomas: Phenotypic Overlap with PHACE Syndrome |
| Q41771661 | Use of propranolol in treating hemangiomas. |
| Q39096010 | Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment |
| Q37657969 | When to stop propranolol for infantile hemangioma |
Search more.